CLINICAL_TRIALS
trial_result
· 2012-12-28
Clinical Trial Update: A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma [Phase 2]
Summary
Phase 2 study evaluating a modified-release prednisone tablet (Lodotra) for nocturnal asthma, with results posted by Amgen.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2012-12-28